The Schall Law Firm Reminds Investors of Class Action Lawsuit Against Edwards Lifesciences Corporation

Los Angeles, CA / Accesswire / November 27, 2024

The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Edwards Lifesciences Corporation (“Edwards Lifesciences” or “the Company”) (NYSE:EW) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company’s securities between February 6, 2024 and July 24, 2024, inclusive (the “Class Period”), are encouraged to contact the firm before December 13, 2024.

The lawsuit alleges that Edwards Lifesciences made materially false and/or misleading statements and/or failed to disclose that: (1) the Company’s SAPIEN 3 Ultra system had numerous material defects or deficiencies; (2) the Company attempted to address Product Complaint Information-RMAs using a remediation process that resulted in a double reporting of complaints and RMAs; and (3) as a result, the Company’s public statements were materially false and misleading at all relevant times.

How does this affect me?

If you are an investor who purchased Edwards Lifesciences Corporation securities between February 6, 2024, and July 24, 2024, you may be eligible to participate in the class action lawsuit and seek compensation for any losses incurred due to the alleged violations of securities laws by the Company.

How does this affect the world?

This class action lawsuit against Edwards Lifesciences Corporation highlights the importance of transparency and accountability in corporate governance. When companies fail to disclose material information that could impact investors’ decisions, it erodes trust in the financial markets and can have far-reaching consequences. By holding companies accountable for their actions, investors can help ensure that companies operate ethically and responsibly, benefiting both shareholders and the broader financial ecosystem.

Conclusion

In conclusion, the class action lawsuit against Edwards Lifesciences Corporation serves as a reminder of the importance of due diligence and transparency in investing. Investors should always be vigilant and conduct thorough research before making investment decisions to mitigate risks and protect their financial interests.